Axel Haferkamp

9.5k total citations
336 papers, 5.5k citations indexed

About

Axel Haferkamp is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Axel Haferkamp has authored 336 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Pulmonary and Respiratory Medicine, 93 papers in Surgery and 88 papers in Molecular Biology. Recurrent topics in Axel Haferkamp's work include Urinary Bladder and Prostate Research (55 papers), Renal cell carcinoma treatment (52 papers) and Bladder and Urothelial Cancer Treatments (48 papers). Axel Haferkamp is often cited by papers focused on Urinary Bladder and Prostate Research (55 papers), Renal cell carcinoma treatment (52 papers) and Bladder and Urothelial Cancer Treatments (48 papers). Axel Haferkamp collaborates with scholars based in Germany, United States and Austria. Axel Haferkamp's co-authors include Markus Hohenfellner, Eva Juengel, Roman A. Blaheta, Igor Tsaur, Hendrik Borgmann, Jesco Pfitzenmaier, Georg Bartsch, Nina Wagener, Jasmina Makarević and Stephan Buse and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Axel Haferkamp

318 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Haferkamp Germany 41 2.0k 1.8k 1.1k 885 882 336 5.5k
John M. Fitzpatrick Ireland 43 1.9k 1.0× 1.7k 0.9× 979 0.9× 819 0.9× 726 0.8× 208 5.9k
Julio M. Pow‐Sang United States 38 1.3k 0.6× 1.1k 0.6× 1.7k 1.6× 702 0.8× 1.3k 1.5× 214 4.7k
Jonathan L. Wright United States 39 2.0k 1.0× 1.1k 0.6× 2.1k 2.0× 912 1.0× 826 0.9× 255 5.0k
Gabriel P. Haas United States 37 3.3k 1.6× 1.1k 0.6× 1.6k 1.5× 448 0.5× 1.3k 1.5× 167 5.8k
Christopher Weight United States 44 4.2k 2.0× 2.7k 1.5× 2.2k 2.1× 526 0.6× 626 0.7× 218 6.2k
Todd M. Morgan United States 46 3.9k 1.9× 1.9k 1.0× 2.5k 2.4× 811 0.9× 2.2k 2.5× 307 8.3k
Swen‐Olof Andersson Sweden 34 3.4k 1.7× 698 0.4× 1.3k 1.3× 460 0.5× 1.3k 1.4× 59 5.6k
Cary N. Robertson United States 42 3.1k 1.5× 1.8k 1.0× 1.3k 1.3× 426 0.5× 2.3k 2.6× 132 8.1k
D. Robert Siemens Canada 38 1.3k 0.6× 1.0k 0.6× 1.3k 1.3× 439 0.5× 1.4k 1.6× 219 5.1k
Byung Ha Chung South Korea 36 3.5k 1.7× 578 0.3× 1.1k 1.0× 917 1.0× 684 0.8× 282 5.2k

Countries citing papers authored by Axel Haferkamp

Since Specialization
Citations

This map shows the geographic impact of Axel Haferkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Haferkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Haferkamp more than expected).

Fields of papers citing papers by Axel Haferkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Haferkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Haferkamp. The network helps show where Axel Haferkamp may publish in the future.

Co-authorship network of co-authors of Axel Haferkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Haferkamp. A scholar is included among the top collaborators of Axel Haferkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Haferkamp. Axel Haferkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Markowitsch, Sascha D., Jochen Rutz, Felix K.‐H. Chun, et al.. (2024). Survey of Physicians and Healers Using Amygdalin to Treat Cancer Patients. Nutrients. 16(13). 2068–2068. 2 indexed citations
3.
Markowitsch, Sascha D., Thao Pham, Jochen Rutz, et al.. (2024). Growth of Renal Cancer Cell Lines Is Strongly Inhibited by Synergistic Activity of Low-Dosed Amygdalin and Sulforaphane. Nutrients. 16(21). 3750–3750. 1 indexed citations
4.
Xie, Hui, Jochen Rutz, Sebastian Maxeiner, et al.. (2024). Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro. Nutrients. 16(5). 623–623. 3 indexed citations
5.
Borgmann, Hendrik, Julian P. Struck, Mike Wenzel, et al.. (2021). Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in Urology. Urologia Internationalis. 105(3-4). 199–205. 9 indexed citations
6.
Mager, René, Katharina Böhm, Anita Thomas, et al.. (2019). Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer. Urologic Oncology Seminars and Original Investigations. 37(12). 999–1005. 6 indexed citations
7.
Thomas, Christian, Anita Thomas, Robert Dotzauer, et al.. (2019). Development of symptomatic lymphoceles after radical prostatectomy and pelvic lymph node dissection is independent of surgical approach: a single-center analysis. International Urology and Nephrology. 51(4). 633–640. 18 indexed citations
8.
Salomon, Georg, J. PHILIP SAUL, Meike Schneider, et al.. (2018). Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial. World Journal of Urology. 36(6). 871–876. 6 indexed citations
9.
Thomas, Christian, Maximilian Peter Brandt, Igor Tsaur, et al.. (2018). Docetaxel-rechallenge in castration-resistant prostate cancer: defining clinical factors for successful treatment response and improvement in overall survival. International Urology and Nephrology. 50(10). 1821–1827. 11 indexed citations
10.
11.
Vallo, Stefan, et al.. (2016). What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospital. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Reiter, Michael, I Eckhardt, Axel Haferkamp, & Simone Fulda. (2016). Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis. Cancer Letters. 375(1). 1–8. 11 indexed citations
13.
Reiter, Michael, M. Kurosch, & Axel Haferkamp. (2015). Nierenzellkarzinom: Medikamentöse Therapie und prognostische Modelle. Urologe A. 54(5). 735–748. 1 indexed citations
14.
Reiter, Michael, M. Kurosch, & Axel Haferkamp. (2015). Nierenzellkarzinom. Der Urologe. 54(5). 735–748. 2 indexed citations
15.
Borgmann, Hendrik, René Mager, Johannes Salem, et al.. (2015). Robotic Prostatectomy on the Web: A Cross-Sectional Qualitative Assessment. Clinical Genitourinary Cancer. 14(4). e355–e362. 13 indexed citations
16.
Makarević, Jasmina, Jochen Rutz, Eva Juengel, et al.. (2014). Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro. PLoS ONE. 9(10). e110244–e110244. 37 indexed citations
17.
Vallo, Stefan, Jasmina Makarević, Eva Juengel, et al.. (2012). Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro. Prostate Cancer and Prostatic Diseases. 15(3). 250–255. 22 indexed citations
18.
Huber, Johannes, Sascha Pahernik, Peter Hallscheidt, et al.. (2010). Risk factors and clinical management of haemorrhage after open nephron‐sparing surgery. British Journal of Urology. 106(10). 1488–1493. 9 indexed citations
19.
Macher‐Goeppinger, Stephan, Sebastian Aulmann, Katrin E. Tagscherer, et al.. (2009). Prognostic Value of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer. Clinical Cancer Research. 15(2). 650–659. 56 indexed citations
20.
Bastian, Patrick J., et al.. (2004). Health-Related Quality-of-Life Following Modified Ureterosigmoidostomy (Mainz Pouch II) as Continent Urinary Diversion. European Urology. 46(5). 591–597. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Fitzpatrick Breakdown of academic impact, for papers by Julio M. Pow‐Sang Breakdown of academic impact, for papers by Jonathan L. Wright Breakdown of academic impact, for papers by Gabriel P. Haas Breakdown of academic impact, for papers by Christopher Weight Breakdown of academic impact, for papers by Todd M. Morgan Breakdown of academic impact, for papers by Swen‐Olof Andersson Breakdown of academic impact, for papers by Cary N. Robertson Breakdown of academic impact, for papers by D. Robert Siemens Breakdown of academic impact, for papers by Byung Ha Chung
Rankless by CCL
2026